Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area gpcr g protein leukotriene receptor'

Search results for: 'research area gpcr g protein leukotriene receptor'

Items 11-20 of 52

Page
per page
  1. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: protein kinase inhibitor
      Soluble in DMSO
  2. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  3. PF-562271
    A8310 PF-562271
     1 Citation
    Target: FAK|Pyk2
    Summary: ATP-competitive FAK inhibitor, reversible
      ≥25.35 mg/mL
  4. Sunitinib malate
    A8255 Sunitinib malate
     2 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  5. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  6. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    Target: EGFR|ErbB
    Summary: ErbB inhibitor
      ≥23.7 mg/mL
  7. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  8. Cediranib (AZD217)
    A1882 Cediranib (AZD217)
    Target: VEGFR
    Summary: VEGFR inhibitor receptor,highly potent
      ≥22.52 mg/mL
  9. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  10. SU 5402
    A3843 SU 5402
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR2/FGFR/PDGFR/EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.8 mg/mL

Items 11-20 of 52

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Axl 2item
  2. ALK 4item
  3. Broad Spectrum Protein Kinase Inhibitor 1 item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 4item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 7item
  10. EphB4 1 item
  11. FAK 4item
  12. FGFR 3item
  13. FLT3 2item
  14. HER2 3item
  15. IGF1R 3item
  16. IRAK 2item
  17. PDGFR 7item
  18. Pyk2 2item
  19. Spleen Tyrosine Kinase (Syk) 1 item
  20. Src 2item
  21. Tie-2 1 item
  22. Trk 3item
  23. VEGFR 11item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 2item
  3. CSF-1R 1 item
  4. FLT3 2item
  5. Eph Receptors 1 item
  6. VEGFR 13item
  7. PDGFR 9item
  8. c-Kit 6item
  9. RET 1 item
  10. IRAK 2item
  11. Bcr-Abl 2item
  12. FGFR 4item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 2item
  15. Src 1 item
  16. Trk Receptors 2item
  17. EGFR 5item
  18. FAK 4item
  19. BMP and Other Activin Receptors 3item
  20. Syk 1 item
  21. ErbB 2item
  22. c-MET 2item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 1 item
  26. HER2 1 item
  27. Pyk2 3item
  28. S1P receptors 1 item
  29. Insulin and Insulin-like Receptors 2item
  30. PKG 1 item
  31. PKA 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. c-Fyn 1 item
  34. AXL 1 item
  35. c-Fms tyrosine kinase 1 item
  36. tropomyosin receptor kinase 1 item
Reported Experiments
  1. Animal Experiments 45item
  2. Cell Experiments 23item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 3item
  5. Breast Cancer 11item
  6. Cancer 39item
  7. Cervical Cancer 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Colon Cancer 1 item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 9item
  12. Glioblastoma 4item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 2item
  15. Liver Cancer 2item
  16. Lung Cancer 5item
  17. Lung Carcinoma 1 item
  18. Lymphoma 1 item
  19. Melanoma 2item
  20. Multiple Myeloma 4item
  21. Myeloma 1 item
  22. Non-small Cell Lung Cancer 4item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 6item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cell Carcinoma 2item
  28. Thyroid Cancer 1 item